ArticleThe Laryngoscope2026
The Impact of Milk Protein Allergy on Pediatric Otitis Media Incidence.
Article in The Laryngoscope, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Impact of Milk Protein Allergy on Pediatric Otitis Media Incidence.The Laryngoscope · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveOtitis media (OM) is among the most prevalent infections in children. This study aims to investigate the correlation between milk protein allergy (MPA) and the incidence of OM in children.
methodPatients aged 2-17 years were identified in the TriNetX United States database and divided into two cohorts based on the presence or absence of MPA (ICD-10-CM code Z91.011). Propensity score matching was employed to balance demographic and clinical characteristics including age, sex, race, and ethnicity. The primary outcome was the incidence of OM, including acute otitis media (AOM), otitis media with effusion (OME), and chronic suppurative otitis media (CSOM) (ICD-10-CM codes H66, H65, and H66.3, respectively). Secondary outcomes included the number of OM instances per patient.
results10,726,154 children were included. After propensity score matching, the final cohorts included 57,531 patients with a mean age of 4.0 years (SD = 3.5). The incidence of OM was significantly higher in the MPA cohort (N = 20,276, 35.2%) compared to the non-MPA cohort (N = 17,143, 29.8%: OR = 1.28, 95% CI = 1.25-1.31, p < 0.001). When stratified by OM type, all types of OM were found to be more common in the MPA cohort compared to the non-MPA cohort (p < 0.001 for all).
conclusionThis study demonstrates a significant association between MPA and an increased risk of OM in pediatric patients. These findings emphasize the importance of early diagnosis and dietary management of MPA to mitigate the risk of OM. Comprehensive care, including tailored preventive strategies, could reduce the burden of OM and improve long-term outcomes for children with MPA. LEVEL OF EVIDENCE: 3:
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.